Tamoxifen: all 215 studies that test it
Page 2 of 3. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome CoronavirusStatus unknownNCT04389580Phase 2
- Thin Endometrium Undergoing Frozen-thawed Embryo TransferStatus unknownNCT04292886Not applicable
- A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent GlioblastomaWithdrawnNCT04200066Phase 1
- Limited Adjuvant Endocrine Therapy for Low Risk Breast CancerActive, not recruitingNCT03917082Phase 2
- Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 MutationStatus unknownNCT03879174Phase 2
- Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive ExpressionCompletedNCT03870399Phase 2
- Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast CancerStatus unknownNCT03373708Phase 2/3
- Tamoxifen in Duchenne Muscular DystrophyCompletedNCT03354039Phase 3
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnNCT03238703Phase 4
- The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast CancersStatus unknownNCT03211572Phase 2
- Treatment With Tamoxifen in Cryptococcal MeningitisCompletedNCT03112031Phase 2
- The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.Status unknownNCT03060304Phase 4
- Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer PatientsCompletedNCT02995772Phase 3
- SFX-01 in the Treatment and Evaluation of Metastatic Breast CancerCompletedNCT02970682Phase 2
- Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.CompletedNCT02866955Phase 2
- Treatment Effect of Tamoxifen on Patients With DMDCompletedNCT02835079Phase 1
- TAmoxifen Versus LIdocaine Cream. A Randomized Clinical Trial for Reducing Pain and Discomfort During MammographyStatus unknownNCT02801786Phase 2/3
- Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and TaxaneCompletedNCT02728622Phase 3
- Tamoxifen and Clomiphene Citrate in Mild Stimulation IVFStatus unknownNCT02690870Phase 4
- Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node MetastasesActive, not recruitingNCT02603679Phase 2
- Tamoxifen in Patients With Oesophageal CancerStatus unknownNCT02513849Phase 1
- Decision Aids for Tamoxifen Treatment in Breast Cancer PatientsStatus unknownNCT02488603Not applicable
- A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the CervixStatus unknownNCT02482740Phase 2
- Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOsCompletedNCT02479256Phase 4
- Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast CancerCompletedNCT02404844Phase 2
- Tamoxifen Treatment in Patients With Motor Neuron DiseaseCompletedNCT02166944Phase 1/2
- Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast CancerStatus unknownNCT02097459Phase 3
- Tamoxifen to Treat Barrett's MetaplasiaTerminatedNCT02089386Early Phase 1
- First-in-Human Dose Escalation Trial in Subjects With Advanced MalignanciesCompletedNCT01971515Phase 1
- Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast CancerCompletedNCT01950182Phase 3
- A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male VolunteersCompletedNCT01821066Phase 1
- A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line ChemotherapyTerminatedNCT01685255Phase 2
- Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast CancerCompletedNCT01612871Phase 4
- Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) UsersActive, not recruitingNCT01579734Phase 3
- Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or NotCompletedNCT01553903Phase 4
- Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-upActive, not recruitingNCT01357772Phase 3
- Adjuvant AI Combined With ZoladexStatus unknownNCT01352091Phase 3
- Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+CompletedNCT01220076Phase 2
- PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM)CompletedNCT01192308Phase 1
- Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 PolymorphismsCompletedNCT01075802Not applicable
- Tamoxifen Citrate in Patients With Breast CancerStatus unknownNCT00963209Phase 3
- Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast CancerCompletedNCT00949598Phase 3
- Exemestane (Aromasine) + Tamoxifen - Breast Neo-AdjuvantCompletedNCT00919399Phase 2
- Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young WomenStatus unknownNCT00912548Phase 3
- Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer PatientsStatus unknownNCT00896155Phase 3
- Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast CancerCompletedNCT00893061Phase 3
- ATAC - Arimidex, Tamoxifen Alone or in CombinationCompletedNCT00849030Phase 3
- ATAC - Endometrial Sub-ProtocolCompletedNCT00814125Phase 3
- ATAC - Bone Density Sub-ProtocolCompletedNCT00784940Phase 3
- ATAC - Pharmacokinetics (PK) Sub-ProtocolCompletedNCT00784862Phase 3
- ATAC - Quality of Life Sub-ProtocolCompletedNCT00784680Phase 3
- Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical TherapyCompletedNCT00749138Phase 1
- German Preoperative Adriamycin Docetaxel StudyCompletedNCT00543829Phase 2
- Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord TumorsCompletedNCT00541138Phase 2
- Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast CancerStatus unknownNCT00538330Not applicable
- Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of TamoxifenTerminatedNCT00532454Phase 2
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant GliomasStatus unknownNCT00492687Phase 2
- Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III MelanomaStatus unknownNCT00492505Phase 2
- Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular MelanomaStatus unknownNCT00489944Phase 2
- Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous CycleStatus unknownNCT00449514Not applicable
- Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal FibrosisStatus unknownNCT00440349Phase 2
- Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast CancerCompletedNCT00424164Phase 1
- Tamoxifen in Treatment of Acute ManiaCompletedNCT00411203Phase 3
- Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical TrialCompletedNCT00375622Phase 2
- Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive PatientsCompletedNCT00309491Phase 3
- Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsCompletedNCT00309478Phase 3
- CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving TamoxifenStatus unknownNCT00305838Phase 2
- Tamoxifen-MRI StudyCompletedNCT00295100Phase 2
- ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.CompletedNCT00291759Phase 3
- Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast CancerCompletedNCT00253539Phase 2
- PROACT - Pre-Operative Arimidex Compared To TamoxifenCompletedNCT00232661Phase 3
- Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]CompletedNCT00214110Phase 2
- Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast CancerTerminatedNCT00210028Phase 2
- Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?CompletedNCT00206544Phase 2
- Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer PatientsTerminatedNCT00206492Phase 2
- A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based TherapyCompletedNCT00189358Phase 2
- Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease SurvivorsCompletedNCT00165308Not applicable
- The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)CompletedNCT00152178Phase 3
- Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the BreastStatus unknownNCT00126464Not applicable
- Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast CancerTerminatedNCT00096369Phase 2
- Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast CancerCompletedNCT00080743Phase 2
- Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or AnastrozoleStatus unknownNCT00077168Phase 2
- Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast CancerWithdrawnNCT00053339Phase 3
- Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast CancerCompletedNCT00052728Phase 2
- Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.CompletedNCT00034125Phase 3
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast CancerCompletedNCT00032136Phase 3
- Examination of Tamoxifen in Acute Mania in Patients With Bipolar I DisorderCompletedNCT00026585Phase 2
- Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem GliomaStatus unknownNCT00024336Phase 2
- Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerTerminatedNCT00016341Phase 3
- Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00010140Phase 3
- Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedNCT00006388Phase 2
- Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast CancerStatus unknownNCT00006030Phase 3
- Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast CancerCompletedNCT00005886Phase 1
- Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast CancerCompletedNCT00004205Phase 3
- Tamoxifen in Treating Women With Breast CancerStatus unknownNCT00003678Phase 3
- Tamoxifen in Treating Patients With Primary Liver CancerCompletedNCT00003424Phase 3
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast CancerStatus unknownNCT00003418Phase 3
- Chemoprevention Therapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003099Phase 2
- Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast CancerStatus unknownNCT00003016Phase 3
- Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast CancerCompletedNCT00002967Phase 3